Questions about practical considerations: What is the titration schedule, and how long before I reach the target dose
Considering the significantly elevated expression levels of GLP-1R in diabetic patients, it is hypothesized that administration of GLP-1R agonists may elevate the risk of breast cancer progression in these patients, thus necessitating particular caution in clinical management [101]
These rates were highly correlated with baseline BMI and included discontinuations for perceived #ExcessiveWeightLoss
Retatrutides Phase 2 trials involved 338 participants across multiple dose groups, with the results published and presented at major medical conferences
Material that is described in commerce as "retatrutide" is therefore either (a) supplied to participants enrolled in an Eli Lilly clinical trial, (b) supplied as a chemical reference standard for laboratory research use only, or (c) sold illicitly, which has been the focus of FDA enforcement [5][6][13][14]
13 , 786767 (2022) J.F.E
